R&D Facilities

Japan

  • Teijin Limited
    Tokyo
    • Material Analysis Research Center
    Chiba
    • Plastics Technical Center
    Ehime
    • Teijin Composites Innovation Center
    • Technology Innovation Center
    Yamaguchi
    • Iwakuni R&D Center
    Hiroshima
    • Processing Development Section
  • Toho Tenax Co., Ltd.
    Shizuoka
    • Technical Development Group
  • Teijin Pharma Limited
    Tokyo
    • Medicinal Chemistry Research Laboratories
    • Pharmaceutical Discovery Research Laboratories
    • Bio-medical Engineering Laboratories
    Yamaguchi
    • Pharmaceutical Products Research Laboratories
  • Teijin Film Solutions Limited
    Gifu
    • Research and Development Center

USA

  • Continental Structural Plastics

Germany

  • Toho Tenax Europe GmbH Laboratory
  • Teijin Aramid GmbH Research Institute

UK

  • DuPont Teijin Films U.K. Limited Research Center

The Netherlands

  • Teijin Aramid B.V. Institute

France

  • Continental Structural Plastics

China

  • Teijin Chemicals Plastic Compounds Shanghai Ltd. Technical Center
  • Teijin Product Development China Co., Ltd.

Core Corporate R&D Facilities

Iwakuni R&D Center

Iwakuni R&D Center

Incubation for the creation of new businesses is a key process in linking technological developments to technologies that create value for customers in the form of products. To perform this incubation function, we have established the Iwakuni R&D Center in Iwakuni and setup R&D infrastructure to research the process of creating new businesses from initial R&D to the pilot stage. We have also established the Open Laboratory to promote joint development with our customers.

Technology Development Center

 

Technology Development Center is promoting development of composite materials and of solutions combining products and services with an aim to strengthen solution development capability in the field of high-performance materials.

Tokyo Research Center

Tokyo Research Center

Tokyo Research Center carries out R & D mainly on healthcare business such as pharmaceuticals and home healthcare. It will play a central role, jointly with the healthcare development taskforce in the Iwakuni area, in expanding existing business and core R & D in the new healthcare field.